Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

Objective Early prediction of long-term outcomes in patients with systemic lupus erythematosus (SLE) remains a great challenge in clinical practice. Our study aims to develop and validate predictive ...

Clotting is a serious complication of systemic lupus erythematosus (SLE) for several reasons. First, clotting can cause persistent disability and death or fetal loss in pregnant women. Second, the ...